WO2006129110A3 - Assay - Google Patents

Assay Download PDF

Info

Publication number
WO2006129110A3
WO2006129110A3 PCT/GB2006/002030 GB2006002030W WO2006129110A3 WO 2006129110 A3 WO2006129110 A3 WO 2006129110A3 GB 2006002030 W GB2006002030 W GB 2006002030W WO 2006129110 A3 WO2006129110 A3 WO 2006129110A3
Authority
WO
WIPO (PCT)
Prior art keywords
ace2
fragment
assay
eclampsia
angiotensin
Prior art date
Application number
PCT/GB2006/002030
Other languages
French (fr)
Other versions
WO2006129110A2 (en
Inventor
Manu Vatish
David Charles Pritlove
Original Assignee
Univ Warwick
Manu Vatish
David Charles Pritlove
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Warwick, Manu Vatish, David Charles Pritlove filed Critical Univ Warwick
Publication of WO2006129110A2 publication Critical patent/WO2006129110A2/en
Publication of WO2006129110A3 publication Critical patent/WO2006129110A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Abstract

The invention relates to a method for screening for pre-eclampsia in a mammal, such as a human, by determining the amount of ACE2 (Angiotensin-converting Enzyme 2), variant, or fragment of ACE2, or mRNA encoding the ACE2. Additionally a new fragment of ACE2 has been identified and isolated. Reagents and kits for carrying out the method are also provided.
PCT/GB2006/002030 2005-06-02 2006-06-02 Assay WO2006129110A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0511279A GB0511279D0 (en) 2005-06-02 2005-06-02 Assay
GB0511279.2 2005-06-02

Publications (2)

Publication Number Publication Date
WO2006129110A2 WO2006129110A2 (en) 2006-12-07
WO2006129110A3 true WO2006129110A3 (en) 2007-02-15

Family

ID=34835037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/002030 WO2006129110A2 (en) 2005-06-02 2006-06-02 Assay

Country Status (2)

Country Link
GB (1) GB0511279D0 (en)
WO (1) WO2006129110A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102033100B (en) 2009-09-25 2013-03-13 同方威视技术股份有限公司 Detecting system of ion migration spectrometer (IMS) using doping agent and detecting method thereof
WO2022012688A1 (en) * 2020-07-17 2022-01-20 Shenzhen Bay Laboratory Ace2-ig fusion variants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000367A1 (en) * 2002-06-19 2003-12-31 University Health Network Ace2 activation for treatment of heart, lung and kidney disease and hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000367A1 (en) * 2002-06-19 2003-12-31 University Health Network Ace2 activation for treatment of heart, lung and kidney disease and hypertension

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BROSNIHAN K BRIDGET ET AL: "Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.", HYPERTENSION (BALTIMORE), vol. 42, no. 4 Part 2, October 2003 (2003-10-01), pages 749 - 753, XP002405387, ISSN: 0194-911X *
DANILCZYK U ET AL: "Physiological roles of angiotensin-converting enzyme 2", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, vol. 61, no. 21, November 2004 (2004-11-01), pages 2714 - 2719, XP002405388, ISSN: 1420-682X *
PRITLOVE D C ET AL: "EMERGING TECHNOLOGIES FOR THE IDENTIFICATION OF THERAPEUTIC TARGETS FOR THE MANAGEMENT OF PRE-ECLAMPSIA", EXPERT OPINION ON THERAPEUTIC TARGETS, ASHLEY PUBLICATIONS, LONDON, GB, vol. 8, no. 6, 2004, pages 507 - 514, XP008061230, ISSN: 1472-8222 *
VALDES G ET AL: "Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies", PLACENTA, vol. 27, no. 2-3, March 2006 (2006-03-01), pages 200 - 207, XP005199238, ISSN: 0143-4004 *
VALDES GLORIA ET AL: "Distribution of angiotensin-(1-7) and ACE2 in human placenta of early and term normotensive pregnancy and preeclampsia.", JOURNAL OF HYPERTENSION, vol. 22, no. Suppl. 1, February 2004 (2004-02-01), & 20TH SCIENTIFIC MEETING OF THE INTERNATIONAL-SOCIETY-OF-HYPERTENSION; SAO PAULO, BRAZIL; FEBRUARY 15 -19, 2004, pages S65, XP009074076, ISSN: 0263-6352 *

Also Published As

Publication number Publication date
GB0511279D0 (en) 2005-07-13
WO2006129110A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2007076439A3 (en) Methods and marker combinations for screening for predisposition to lung cancer
WO2007075891A3 (en) Multiplex assays using magnetic and non-magnetic particles
WO2007062090A8 (en) Methods and compositions related to b cell assays
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2006031644A3 (en) Immobilized probes and methods of detecting conformationally altered prion proteins
WO2006108674A3 (en) Elite event a2704-12 and methods and kits for identifying such event in biological samples
WO2005017646A3 (en) System, software and methods for biomarker identification
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
GB0600916D0 (en) detecting and predicting pre-eclampsia
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
WO2007003670A8 (en) Fibrosis markers
WO2006102526A3 (en) Identification of biomarkers by serum protein profiling
WO2006085121A3 (en) Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
WO2008008858A3 (en) Cellspot™ applications
WO2006110748A3 (en) Response gene to complement 32 (rgc-32) in disease
WO2007087521A3 (en) Cd86 and cd80 receptor competition assays
WO2007134818A3 (en) Method for diagnosing mitochondrial dysfunction
WO2006058334A3 (en) Prticle-based multiplex assay for identifying glycosylation
AU2006254891A8 (en) Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
WO2007076240A3 (en) Compositions and methods for lipoprotein uptake assays
WO2007082173A3 (en) Compositions and methods for enhancing the identification of prion protein prpsc
ATE497779T1 (en) ENZYMES FOR REDUCING IMMUNOLOGICAL STRESS
WO2006129110A3 (en) Assay

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06744084

Country of ref document: EP

Kind code of ref document: A2